CellGenix human umbilical cord mesenchymal stem cells (hUC-MSC) are self-renewing cells that hold great therapeutic promise in the field of cell-based tissue engineering and regenerative medicine. They are used for the prevention or treatment of Graft versus Host Disease (GvHD) and as feeder cells for co-culturing of cord blood cells resulting in improved expansion of hematopoietic progenitors.
CellGenix hUC-MSC are isolated from umbilical cord tissue by enzymatic digestion after removal of vessels. The cells are assayed for their expansion capacity, immune phenotype, and their potential to differentiate in vitro into adipogenic, osteogenic and chondrogenic lineages.
Please note that this product is only available within the European Union.
CellGenix® human umbilical cord mesenchymal stem cells
CellGenix® hUC-MSC (only available in Europe)
|0.5 million cells/vial|
|1 million cells/vial|
- Xeno-free feeder cells
- High proliferation rate
- Batch specific Certificate of Analysis available
- Preclinical ex vivo research of hUC-MSCs
- MSC co-culture of cord blood cells
|Characteristics||CellGenix® hUC-MSC have been cultured under serum-free conditions using CellGenix® MSC Medium containing 5ng/ml CellGenix® rh FGF-2|
|Phenotypic properties||CD73/CD90/CD105: ≥ 95% positive determined by flow cytometry|
| ||CD34: ≥95% negative determined by flow cytometry|
|Freezing Medium||Serum-free, containing human serum albumin (HSA) and dimethyl sulfoxide (DMSO)|
|Viability after thawing||≥ 80%|
|Differentiation capacity||Adipogenesis, chondrogenesis, osteogenesis|
|Test for microbial & viral contaminants|
|Bacteria and fungi, Mycoplasma, HIV-1, HBV,HCV|
|Intended use||For preclinical ex vivo use. Not intended for human in vivo application.|
|Shipment||Frozen (dry ice)|
|Storage||Store in liquid nitrogen. Storage at higher temperatures (-80ºC) may cause irreversible cell damage|
|Culture||Please refer to the handling instructions for further thawing and cultivation details (on request)|